データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
502487-67-4CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3JFIBVDBTCDTBRH-REZTVBANSA-NSQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
使用SQ109 has been used: as an antitubercularagent to study its interactions with mycobacterial membrane proteins large 3 (MmpL3) binding pocket as a positive control to determine the minimum inhibitory concentration (MIC) of ohmyungsamycins (OMS) A and B against Mycobacterium tuberculosis(Mtb) using the resazurin microtiter assay (REMA) plate method as an inhibitor of MmpL3 to explore the utility of mycobacterial CRISPR interference for validating target gene essentiality and compound mode of action
一般的な説明SQ109 is a 1,2-ethylenediamine, which is related to ethambutol.
502487-67-4DTXSID30964540CHEMBL561057